Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
CASE REPORTS

Urosepsis with Actinobaculum schaalii and Aerococcusurinae

P. D. J. Sturm, J. Van Eijk, S. Veltman, E. Meuleman, T. Schülin
P. D. J. Sturm
1Department of Medical Microbiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: P.Sturm@mmb.umcn.nl
J. Van Eijk
2Department of Neurology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Veltman
1Department of Medical Microbiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. Meuleman
3Department of Urology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Schülin
1Department of Medical Microbiology
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.44.2.652-654.2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Actinobaculum was isolated from urine only after prolonged incubation in 5% CO2 after discrepancy between urine Gram stain and initial culture results was observed. Additional patients were diagnosed using this method. The prevalence of Actinobaculum species in urinary tract infections is underestimated since it is not isolated by routine urine culture procedures.

CASE REPORT

A 78-year-old man was admitted to the neurology ward with a subdural hematoma and contusio cerebri following a fall. An indwelling bladder catheter was placed because of urinary incontinence from a coexisting delirium. After 3 weeks of admission, the patient developed an episode of fever with a temperature of 39°C, nausea, vomiting, tachycardia, and hypertension. C-reactive protein was 155 mg/liter, and leukocytes were 14.0 × 109/liter (90% neutrophils). Urine microscopy of sedimented urine showed more than 50 leukocytes and 25 to 50 erythrocytes per field (×400), hyaline casts, and bacteria. A urosepsis was assumed, and the patient was empirically treated with ceftriaxone (1,000 mg every 24 h [q24h] intravenously) and gentamicin (5 mg/kg q24h intravenously) for the first 48 h. From both urine and blood collected on the same day, Actinobaculum schaalii and Aerococcus urinae were cultured.

Gram stain of uncentrifuged urine showed gram-positive rods and gram-positive cocci in clusters in the presence of many leukocytes (>20 leukocytes per field [×100]) (Fig. 1). Poor growth of gram-positive cocci was observed on blood agar and MacConkey agar after overnight culture at 37°C in ambient air. The isolate was identified as Aerococcus species by phenotypic tests (colony morphology, Gram stain morphology, catalase, growth in 6.5% NaCl, pyrrolidonyl-arylamidase, leucine-aminopeptidase,β -glucuronidase, hippurate hydrolysis, and vancomycin susceptibility) and was confirmed to be Aerococcus urinae by sequence analysis of 16S rRNA DNA. Growth of gram-positive rods on blood agar and not Mac- Conkey was present only after 48 h of reincubation at 37°C in 5% CO2. After subculture, growth was better on blood agar than on chocolate agar. Growth was best in 5% CO2 and equal under anaerobic conditions and in ambient air. After 24 h, colonies were pinpoint. After 48 h, colonies were nonhemolytic, dome-shaped, and glistening gray, with entire edges ranging in size from 0.5 to 1 mm appearing as two separate isolates. Catalase and oxidase reactions were negative. Motility by hanging drop was negative. Gram stain of a 24-h liquid culture (Brewer thioglycolate broth) showed irregular staining gram-positive rods with a diphteroid appearance, including Chinese-character configuration. Bacteria were nonspore-forming and not acid fast with a modified Kinyoun stain or Ziehl-Neelsen stain. The biochemical test results obtained with API Coryne (API Laboratory Products, bioMerieux, France) were as follows: negative results for nitrate reduction; positive results for pyrazinamidase, pyrrolidonyl arylamidase, and α-glucosidase; negative results for alkaline phosphatase, β-glucuronidase,β -galactosidase, N-acetyl-β-glucosaminidase, urease, gelatin hydrolysis, and esculine hydrolysis; and fermentation of ribose, xylose, maltose, and sucrose. As in a previous report, the API Coryne system resulted in profile code 6010621, associated with poor identification of Gardnerella vaginalis (6). The absence of beta-hemolysis on agar containing human blood and resistance to metronidazole were inconsistent with this identification. 16S rRNA gene sequence analysis showed 99% sequence similarity with A. schaalii. A. urinae and A. schaalii were also isolated from blood, each separately, from the anaerobic bottle of two blood culture sets after 24 and 48 h incubation, respectively, using the BACTEC 9240 (Becton Dickinson, Cockeysville, Md.). In vitro susceptibility was performed by the Kirby-Bauer disk diffusion method on Columbia blood agar in 5% CO2 using 0.5 McFarland inoculum. According to the Clinical and Laboratory Standards Institute criteria for Streptococcus spp., the isolate was susceptible to penicillin, amoxicillin, ceftriaxone, tetracycline, clarithromycin, clindamycin, nitrofurantoin, and co-trimoxazole. No zone was present around ciprofloxacin.

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

A Gram stain of uncentrifuged urine shows gram-positive rods and gram-positive cocci in clusters in the presence of manyleukocytes (magnification,× 1,000).

The patient responded well after 7 days of therapy with ceftriaxone. The urinary catheter was removed, and treatment was continued with 500 mg amoxicillin q6h orally for another 14 days, guided by the in vitro susceptibility results. A urologic investigation that was performed because of persistent macroscopic hematuria 1 week after completion of treatment revealed no signs of urinary tract obstruction or malignancy. Cystoscopy showed a diffuse cystitis, and empirical treatment was started with ciprofloxacin. This time, a urine culture showed A. schaalii only. Blood cultures were not collected. The patient's symptoms improved after treatment with ciprofloxacin. However, since the isolate showed in vitro resistance to ciprofloxacin and urine cultures remained positive, ciprofloxacin was switched to 960 mg co-trimoxazole q12h orally for another 4 weeks under the presumptive diagnosis of chronic prostatitis. After completion of treatment, there were no symptoms of urinary tract infection. A urine specimen showed no leukocytes, and the culture was negative.

Urinary tract infections are predominantly caused by members of the family Enterobacteriaceae. However, gram-positive bacteria and polymicrobial infections are not uncommon in patients with complicated and nosocomial urinary tract infections (7).

The current case describes a dual infection of A. schaalii and A. urinae in the urinary tract with bacteremia in an elderly man with an indwelling urinary catheter. In recent years, A. urinae has become an established albeit rare pathogen in urinary tract infections predominantly in elderly patients and has been reported to be a cause of sepsis and endocarditis as well (1, 9). In contrast, cases of human infection with Actinobaculum species are limited to a few reports (2-6, 8).

Actinobaculum is a gram-positive rod closely related to the genus Actinomyces and was first described as a cause of human infection in 1997 (5). Currently, four species within the genus have been described, Actinobaculum suis, A. schaalii, Actinobaculum massiliae, and A. urinale, and the latter three have been described in cases of human infection for six patients. In one patient, the organism was isolated from a skin abscess (8). It was cultured from urine in two patients with cystitis and one with pyelonephritis (3, 4, 6). Actinobaculum was isolated from blood in a patient with chronic pyelonephritis and a patient with chronic renal failure (2, 5). In the latter two patients, the urinary tract was identified as a possible source of bacteremia but was not confirmed microbiologically.

In the current case, A. schaalii was cultured from both urine and blood, which shows it to be a uropathogen with invasive potential. As in the previous reports, Actinobaculum was isolated from urine only after prolonged incubation in 5% CO2, which was done because of the discrepancy between urine Gram stain and initial culture results. As in most laboratories, routine urine cultures are incubated only overnight at 37°C in ambient air using Columbia blood agar and MacConkey agar. Thus, the dual infection of the urinary tract and the source of the bacteremia with A. schaalii would have been missed without routine Gram stain of the urine, which was recently introduced in our laboratory. Although routine urine Gram stain may not be cost-effective in most laboratory settings, it may be an important diagnostic adjunct in selected patients with a high suspicion of urinary tract infection and a negative routine urinary culture. Over a 6-month period, prolonged incubation in 5% CO2 of urine that showed significant leucocyturia and gram-positive rods on microscopy in the absence of contamination resulted in four additional cases of urinary tract infection with A. schaalii (n= 2), A. urinale, and A. massiliae. All four patients were males between 38 and 90 years of age with underlying urological conditions, i.e., longstanding lower urinary tract symptoms of unknown origin, neurogenic bladder due to paralysis for which intermittent catheterization was needed (n = 2), and urethra stricture due to lichen sclerosus et atrophicus.

The delayed growth of gram-positive rods on blood agar after incubation in 5% CO2 or under anaerobic conditions from urine with significant pyuria and of gram-positive rods on urine Gram stain is suggestive of infection with Actinobaculum spp. Although the growth of the isolate described here was stimulated by CO2, others have reported Actinobaculum to be an aerotolerant anaerobic bacterium (2, 8). The API Coryne system can be used to further characterize such isolates. The test results obtained with API Coryne were in keeping with the biochemical characteristics of A. schaalii that have been summarized in previous reports, including the negative urease test which distinguishes A. schaalii from A. urinale (2, 3, 6).

Besides the importance of making a clinical and microbiological diagnosis in a patient, it is important to be informed on the prevalence of the various etiologies of urinary tract infection in specific patient groups and their susceptibility to the antimicrobials used. In this case, the A. schaalii isolate, which was susceptible in vitro to most of the drugs commonly used for urinary tract infections, was resistant to ciprofloxacin, which is a first-line antibiotic in the treatment of prostatitis. All four additional isolates were susceptible to the beta-lactam antibiotics, tetracycline and nitrofurantoin; two were resistant to co-trimoxazole; and one was intermediate susceptible to clarithromycin and resistant to clindamycin. The inhibition zones around ciprofloxacin were 40 mm, 18 mm (two isolates), and 6 mm (no zone).

In conclusion, this report adds five additional patients to the six published cases of Actinobaculum infection since its first description as a cause of human infection in 1997 (5). Actinobaculum infections appear to occur in patients with underlying urological pathology. Since there are only a few reports, the invasive potential of Actinobaculum is likely to be limited. However, the prevalence of Actinobaculum species in urinary tract infections is underestimated since it is not isolated by routine urine culture procedures, and routine urine Gram stain is not performed in many laboratories. Urine Gram stain is an important diagnostic tool for patients with a high suspicion of urinary tract infection but negative routine urinary culture, especially in the presence of structural abnormalities of the urinary tract.

FOOTNOTES

    • Received 20 September 2005.
    • Returned for modification 7 November 2005.
    • Accepted 16 November 2005.
  • Copyright © 2006 American Society for Microbiology

REFERENCES

  1. 1.↵
    Ebnother, C., M. Altwegg, J. Gottschalk, J. D. Seebach, and A. Kronenberg. 2002. Aerococcus urinae endocarditis: case report and review of the literature.Infection30:310-313.
    OpenUrlCrossRefPubMed
  2. 2.↵
    Fendukly, F., and B. Osterman. 2005. Isolation of Actinobaculum schaalii and Actinobaculum urinale from a patient with chronic renal failure. J. Clin. Microbiol.43:3567-3569.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    Greub, G., and D. Raoult. 2002. “Actinobaculum massiliae,” a new species causing chronic urinary tract infection. J. Clin. Microbiol.40:3938-3941.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Hall, V., M. D. Collins, R. A. Hutson, E. Falsen, E. Inganas, and B. I. Duerden. 2003. Actinobaculum urinale sp. nov., from human urine. Int. J. Syst. Evol. Microbiol.53:679-682.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Lawson, P. A., E. Falsen, E. Akervall, P. Vandamme, and M. D. Collins. 1997. Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov. Int. J. Syst. Bacteriol.47:899-903.
    OpenUrlCrossRefPubMed
  6. 6.↵
    Pajkrt, D., A. M. Simoons-Smit, P. H. Savelkoul, J. van den Hoek, W. W. Hack, and A. M. van Furth. 2003 . Pyelonephritis caused by Actinobaculum schaalii in a child with pyeloureteral junction obstruction.Eur. J. Clin. Microbiol. Infect. Dis.22:438-440.
    OpenUrlCrossRefPubMed
  7. 7.↵
    Ronald, A. 2002. The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med.113(Suppl. 1A):14S-19S.
    OpenUrlCrossRefPubMed
  8. 8.↵
    Waghorn, D. J. 2004. Actinobaculum massiliae: a new cause of superficial skin infection.J. Infect.48:276-277.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Zhang, Q., C. Kwoh, S. Attorri, and J. E. Clarridge III. 2000 . Aerococcus urinae in urinary tract infections. J. Clin. Microbiol.38:1703-1705.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Urosepsis with Actinobaculum schaalii and Aerococcusurinae
P. D. J. Sturm, J. Van Eijk, S. Veltman, E. Meuleman, T. Schülin
Journal of Clinical Microbiology Feb 2006, 44 (2) 652-654; DOI: 10.1128/JCM.44.2.652-654.2006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Urosepsis with Actinobaculum schaalii and Aerococcusurinae
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Urosepsis with Actinobaculum schaalii and Aerococcusurinae
P. D. J. Sturm, J. Van Eijk, S. Veltman, E. Meuleman, T. Schülin
Journal of Clinical Microbiology Feb 2006, 44 (2) 652-654; DOI: 10.1128/JCM.44.2.652-654.2006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • CASE REPORT
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Actinomycetaceae
Actinomycetales Infections
Gram-Positive Bacterial Infections
sepsis
Streptococcaceae
Urinary Tract Infections

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X